Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
September-2022 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2022 Volume 24 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

VEGF‑mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma

  • Authors:
    • Preety Rawal
    • Dinesh Mani Tripathi
    • Vikrant Nain
    • Savneet Kaur
  • View Affiliations / Copyright

    Affiliations: School of Biotechnology, Gautam Buddha University, Greater Noida, Uttar Pradesh 201312, India, Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, Delhi 110070, India
    Copyright: © Rawal et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 315
    |
    Published online on: July 15, 2022
       https://doi.org/10.3892/ol.2022.13435
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The purpose of the present study was to evaluate the effects of vascular endothelial growth factor (VEGF) on tumorigenic properties in two‑dimensional (2D) and three‑dimensional (3D) cultures of hepatoma cells. The proliferation and invasion of hepatoma cells was assessed using wound healing, chemotaxis Transwell, invasion, tube‑forming and hanging drop assays in both 2D and 3D cultures. The expression levels of epithelial‑mesenchymal transition (EMT) and stemness markers were analysed using reverse transcription‑quantitative PCR (RT‑qPCR) for mRNA expression and immunofluorescence assay for protein expression. To validate the role of VEGF in tumour growth, a VEGF receptor (VEGFR) inhibitor (sorafenib) was used. The results demonstrated that the hepatoma cells formed 3D spheroids that differed in size and density in the absence and presence of the growth factor, VEGF. In all spheroids, invasion and angiogenesis were more aggressive in 3D cultures in comparison to 2D conditions following treatment with VEGF. Mechanistically, the VEGF‑mediated increase in the levels of EMT markers, including Vimentin, N‑cadherin 2 (Cadherin 2) and Thy‑1 Cell Surface Antigen was observed in the 2D and 3D cultures. Sorafenib treatment for 24 h culminated in a marked reduction in cell migration, cell‑cell adhesion, spheroid compaction and EMT gene expression in 3D models as compared to the 2D models. On the whole, the findings of the present study suggested that as compared to the 2D cell cultures, 3D cell cultures model may be used as a more realistic model for the study of tumour growth and invasion in the presence of angiogenic factors, as well as for tumour inhibitor screening.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Forner A, Reig M and Bruix J: Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018. View Article : Google Scholar

2 

Zhang Y, Gao X, Zhu Y, Kadel D, Sun H, Chen J, Luo Q, Sun H, Yang L, Yang J, et al: The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res. 37:932018. View Article : Google Scholar : PubMed/NCBI

3 

Ma S, Pradeep S, Hu W, Zhang D, Coleman R and Sood A: The role of tumor microenvironment in resistance to anti-angiogenic therapy. F1000Res. 7:3262018. View Article : Google Scholar : PubMed/NCBI

4 

Jiang Z, Zhai X, Shi B, Luo D and Jin B: KIAA1199 overexpression is associated with abnormal expression of EMT markers and is a novel independent prognostic biomarker for hepatocellular carcinoma. Onco Targets Ther. 11:8341–8348. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Li L and Li W: Epithelial-mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation. Pharmacol Ther. 150:33–46. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Silvestre JS, Lévy BI and Tedgui A: Mechanisms of angiogenesis and remodelling of the microvasculature. Cardiovasc Res. 78:201–202. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Zhao W, Zhao T, Huang V, Chen Y, Ahokas RA and Sun Y: Platelet-derived growth factor involvement in myocardial remodeling following infarction. J Mol Cell Cardiol. 51:830–838. 2011. View Article : Google Scholar

8 

Crivellato E, Nico B, Vacca A, Djonov V, Presta M and Ribatti D: Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo. Leukemia. 18:331–336. 2004. View Article : Google Scholar

9 

Zhan X, Wang F, Bi Y and Ji B: Animal models of gastrointestinal and liver diseases. Animal models of acute and chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 311:G343–G355. 2016. View Article : Google Scholar

10 

Liu S, Sun Y, Jiang M, Li Y, Tian Y, Xue W, Ding N, Sun Y, Cheng C, Li J, et al: Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase. Hepatology. 66:631–645. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Karunagaran D, Rashmi R and Kumar TR: Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets. 5:117–129. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Fantozzi A, Gruber DC, Pisarsky L, Heck C, Kunita A, Yilmaz M, Meyer-Schaller N, Cornille K, Hopfer U, Bentires-Alj M and Christofori G: VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation. Cancer Res. 74:1566–1575. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Takai A, Dang H, Oishi N, Khatib S, Martin SP, Dominguez DA, Luo J, Bagni R, Wu X, Powell K, et al: Genome-wide RNAi screen identifies PMPCB as a therapeutic vulnerability in EpCAM+ hepatocellular carcinoma. Cancer Res. 79:2379–2391. 2019. View Article : Google Scholar : PubMed/NCBI

14 

Kozyra M, Johansson I, Nordling Å, Ullah S, Lauschke VM and Ingelman-Sundberg M: Human hepatic 3D spheroids as a model for steatosis and insulin resistance. Sci Rep. 8:142972018. View Article : Google Scholar : PubMed/NCBI

15 

Loessner D, Rizzi SC, Stok KS, Fuehrmann T, Hollier B, Magdolen V, Hutmacher DW and Clements JA: A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread. Biomaterials. 34:7389–7400. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Pingitore P and Romeo S: The role of PNPLA3 in health and disease. Biochim Biophys Acta Mol Cell Biol Lipids. 1864:900–906. 2019. View Article : Google Scholar : PubMed/NCBI

17 

Sarkanen JR, Kaila V, Mannerström B, Räty S, Kuokkanen H, Miettinen S and Ylikomi T: Human adipose tissue extract induces angiogenesis and adipogenesis in vitro. Tissue Eng Part A. 18:17–25. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Chiang IT, Liu YC, Wang WH, Hsu FT, Chen HW, Lin WJ, Chang WY and Hwang JJ: Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells. In Vivo. 26:671–681. 2012.PubMed/NCBI

19 

Bell CC, Hendriks DF, Moro SM, Ellis E, Walsh J, Renblom A, Fredriksson Puigvert L, Dankers AC, Jacobs F, Snoeys J, et al: Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep. 6:251872016. View Article : Google Scholar : PubMed/NCBI

20 

Raghavan S, Mehta P, Horst EN, Ward MR, Rowley KR and Mehta G: Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity. Oncotarget. 7:16948–16961. 2016. View Article : Google Scholar

21 

Murad HY, Bortz EP, Yu H, Luo D, Halliburton GM, Sholl AB and Khismatullin DB: Phenotypic alterations in liver cancer cells induced by mechanochemical disruption. Sci Rep. 9:195382019. View Article : Google Scholar : PubMed/NCBI

22 

D'Angelo E, Natarajan D, Sensi F, Ajayi O, Fassan M, Mammano E, Pilati P, Pavan P, Bresolin S, Preziosi M, et al: Patient-derived scaffolds of colorectal cancer metastases as an organotypic 3D model of the liver metastatic microenvironment. Cancers (Basel). 12:3642020. View Article : Google Scholar

23 

Kapałczyńska M, Kolenda T, Przybyła W, Zajączkowska M, Teresiak A, Filas V, Ibbs M, Bliźniak R, Łuczewski Ł and Lamperska K: 2D and 3D cell cultures-a comparison of different types of cancer cell cultures. Arch Med Sci. 14:910–919. 2018.

24 

Jung HR, Kang HM, Ryu JW, Kim DS, Noh KH, Kim ES, Lee HJ, Chung KS, Cho HS, Kim NS, et al: Cell spheroids with enhanced aggressiveness to mimic human liver cancer in vitro and in vivo. Sci Rep. 7:104992017. View Article : Google Scholar : PubMed/NCBI

25 

Khawar IA, Park JK, Jung ES, Lee MA, Chang S and Kuh HJ: Three dimensional mixed-cell spheroids mimic stroma-mediated chemoresistance and invasive migration in hepatocellular carcinoma. Neoplasia. 20:800–812. 2018. View Article : Google Scholar

26 

Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W and Kunz-Schughart LA: Multicellular tumor spheroids: An underestimated tool is catching up again. J Biotechnol. 148:3–15. 2010. View Article : Google Scholar

27 

Kunz-Schughart LA, Freyer JP, Hofstaedter F and Ebner R: The use of 3-D cultures for high-throughput screening: The multicellular spheroid model. J Biomol Screen. 9:273–285. 2004. View Article : Google Scholar : PubMed/NCBI

28 

Lin RZ and Chang HY: Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J. 3:1172–1184. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Bhattacharya R, Fan F, Wang R, Ye X, Xia L, Boulbes D and Ellis LM: Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion. Br J Cancer. 117:848–855. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Refolo MG, Messa C, Guerra V, Carr BI and D'Alessandro R: Inflammatory mechanisms of HCC development. Cancers (Basel). 12:6412020. View Article : Google Scholar

31 

Muenzner JK, Kunze P, Lindner P, Polaschek S, Menke K, Eckstein M, Geppert CI, Chanvorachote P, Baeuerle T, Hartmann A and Schneider-Stock R: Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potential. J Cell Mol Med. 22:6238–6248. 2018. View Article : Google Scholar : PubMed/NCBI

32 

Rawal P, Siddiqui H, Hassan M, Choudhary MC, Tripathi DM, Nain V, Trehanpati N and Kaur S: Endothelial cell-derived TGF-β promotes epithelial-mesenchymal transition via CD133 in HBx-infected hepatoma cells. Front Oncol. 9:3082019. View Article : Google Scholar

33 

Takai A, Fako V, Dang H, Forgues M, Yu Z, Budhu A and Wang XW: Three-dimensional organotypic culture models of human hepatocellular carcinoma. Sci Rep. 6:211742016. View Article : Google Scholar : PubMed/NCBI

34 

Al Ameri W, Ahmed I, Al-Dasim FM, Ali Mohamoud Y, Al-Azwani IK, Malek JA and Karedath T: Cell Type-specific TGF-β mediated EMT in 3D and 2D models and its reversal by TGF-β receptor kinase inhibitor in ovarian cancer cell lines. Int J Mol Sci. 20:35682019. View Article : Google Scholar

35 

Schneider MR, Hiltwein F, Grill J, Blum H, Krebs S, Klanner A, Bauersachs S, Bruns C, Longerich T, Horst D, et al: Evidence for a role of E-cadherin in suppressing liver carcinogenesis in mice and men. Carcinogenesis. 35:1855–1862. 2014. View Article : Google Scholar : PubMed/NCBI

36 

Melissaridou S, Wiechec E, Magan M, Jain MV, Chung MK, Farnebo L and Roberg K: The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer. Cancer Cell Int. 19:162019. View Article : Google Scholar

37 

Smalley KS, Lioni M, Noma K, Haass NK and Herlyn M: In vitro three-dimensional tumor microenvironment models for anticancer drug discovery. Expert Opin Drug Discov. 3:1–10. 2008. View Article : Google Scholar : PubMed/NCBI

38 

Li F, Wang F and Wu J: Sorafenib inhibits growth of hepatoma with hypoxia and hypoxia-driven angiogenesis in nude mice. Neoplasma. 64:718–724. 2017. View Article : Google Scholar

39 

Rodríguez-Hernández MA, Chapresto-Garzón R, Cadenas M, Navarro-Villarán E, Negrete M, Gómez-Bravo MA, Victor VM, Padillo FJ and Muntané J: Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells. Csell Death Dis. 11:3392020. View Article : Google Scholar

40 

Cheng CC, Chao WT, Shih JH, Lai YS, Hsu YH and Liu YH: Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma. Cancer Chemother Pharmacol. 88:143–153. 2021. View Article : Google Scholar

41 

Ou J, Guan D and Yang Y: Non-contact co-culture with human vascular endothelial cells promotes epithelial-to-mesenchymal transition of cervical cancer SiHa cells by activating the NOTCH1/LOX/SNAIL pathway. Cell Mol Biol Lett. 24:392019. View Article : Google Scholar

42 

Fukuyama K, Asagiri M, Sugimoto M, Tsushima H, Seo S, Taura K, Uemoto S and Iwaisako K: Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters. PLoS One. 16:e02459392021. View Article : Google Scholar : PubMed/NCBI

43 

Zhao Y, Chen Y, Hu Y, Wang J, Xie X, He G, Chen H, Shao Q, Zeng H and Zhang H: Genomic alterations across six hepatocellular carcinoma cell lines by panel-based sequencing. Transl Cancer Res. 7:231–239. 2018. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Rawal P, Tripathi DM, Nain V and Kaur S: VEGF‑mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma. Oncol Lett 24: 315, 2022.
APA
Rawal, P., Tripathi, D.M., Nain, V., & Kaur, S. (2022). VEGF‑mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma. Oncology Letters, 24, 315. https://doi.org/10.3892/ol.2022.13435
MLA
Rawal, P., Tripathi, D. M., Nain, V., Kaur, S."VEGF‑mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma". Oncology Letters 24.3 (2022): 315.
Chicago
Rawal, P., Tripathi, D. M., Nain, V., Kaur, S."VEGF‑mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma". Oncology Letters 24, no. 3 (2022): 315. https://doi.org/10.3892/ol.2022.13435
Copy and paste a formatted citation
x
Spandidos Publications style
Rawal P, Tripathi DM, Nain V and Kaur S: VEGF‑mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma. Oncol Lett 24: 315, 2022.
APA
Rawal, P., Tripathi, D.M., Nain, V., & Kaur, S. (2022). VEGF‑mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma. Oncology Letters, 24, 315. https://doi.org/10.3892/ol.2022.13435
MLA
Rawal, P., Tripathi, D. M., Nain, V., Kaur, S."VEGF‑mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma". Oncology Letters 24.3 (2022): 315.
Chicago
Rawal, P., Tripathi, D. M., Nain, V., Kaur, S."VEGF‑mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma". Oncology Letters 24, no. 3 (2022): 315. https://doi.org/10.3892/ol.2022.13435
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team